OBJECTIVE: To evaluate apraxia in healthy elderly and in patients diagnosed with Alzheimer's disease (AD) and Mild cognitive impairment (MCI). METHODS: We evaluated 136 subjects with an average age of
Participants with Post-COVID condition taking part in the Nautilus study (ClinicalTrials.gov ID: NCT05307575) and the Rehab COVID (ClinicalTrials.gov ID: NCT05846126) recruited by the Consorci Sanitar
